[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857-412-7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lloyd Mitchell Segal", "age": 60, "title": "President, CEO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 932181, "exercisedValue": 0, "unexercisedValue": 5269698}, {"maxAge": 1, "name": "Mr. Steve  Forte CPA", "age": 45, "title": "Executive VP & CFO", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 631996, "exercisedValue": 0, "unexercisedValue": 1765836}, {"maxAge": 1, "name": "Dr. Maria  Koehler M.D., Ph.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 693283, "exercisedValue": 0, "unexercisedValue": 523548}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 641532, "exercisedValue": 0, "unexercisedValue": 1476505}, {"maxAge": 1, "name": "Ms. Robin Thai Garner Kalley", "title": "VP & Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resource", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.06, "dayLow": 1.035, "dayHigh": 1.08, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.06, "regularMarketDayLow": 1.035, "regularMarketDayHigh": 1.08, "payoutRatio": 0.0, "beta": 0.867, "forwardPE": -0.35353532, "volume": 175195, "regularMarketVolume": 175195, "averageVolume": 294621, "averageVolume10days": 224810, "averageDailyVolume10Day": 224810, "bid": 0.7704, "ask": 1.33, "bidSize": 1, "askSize": 1, "marketCap": 44636232, "fiftyTwoWeekLow": 0.982, "fiftyTwoWeekHigh": 4.77, "priceToSalesTrailing12Months": 0.8346809, "fiftyDayAverage": 1.1864, "twoHundredDayAverage": 2.598075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -106221760, "profitMargins": -1.5836501, "floatShares": 22306644, "sharesOutstanding": 42510700, "sharesShort": 1002524, "sharesShortPriorMonth": 1077324, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.023599999, "heldPercentInsiders": 0.0098, "heldPercentInstitutions": 0.80166, "shortRatio": 5.22, "shortPercentOfFloat": 0.039, "impliedSharesOutstanding": 42510700, "bookValue": 3.555, "priceToBook": 0.29535863, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -84689000, "trailingEps": -2.0, "forwardEps": -2.97, "enterpriseToRevenue": -1.986, "enterpriseToEbitda": 1.177, "52WeekChange": -0.7765957, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.05, "targetHighPrice": 8.0, "targetLowPrice": 3.0, "targetMeanPrice": 5.33333, "targetMedianPrice": 5.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 152791008, "totalCashPerShare": 3.594, "ebitda": -90223000, "totalDebt": 1933000, "quickRatio": 6.531, "currentRatio": 6.768, "totalRevenue": 53477000, "debtToEquity": 1.279, "revenuePerShare": 1.261, "returnOnAssets": -0.26760998, "returnOnEquity": -0.46633, "grossProfits": 40099000, "freeCashflow": -44043000, "operatingCashflow": -76445000, "revenueGrowth": -1.0, "grossMargins": 0.74984, "ebitdaMargins": -1.68714, "operatingMargins": -1.72306, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "postMarketChangePercent": 1.85714, "postMarketPrice": 1.0695, "postMarketChange": 0.0195, "regularMarketChange": -0.0200001, "regularMarketDayRange": "1.035 - 1.08", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 294621, "fiftyTwoWeekLowChange": 0.06799996, "fiftyTwoWeekLowChangePercent": 0.0692464, "fiftyTwoWeekRange": "0.982 - 4.77", "fiftyTwoWeekHighChange": -3.72, "fiftyTwoWeekHighChangePercent": -0.7798742, "fiftyTwoWeekChangePercent": -77.65957, "earningsTimestamp": 1741003500, "earningsTimestampStart": 1741003500, "earningsTimestampEnd": 1741003500, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.0, "epsForward": -2.97, "epsCurrentYear": -1.73, "priceEpsCurrentYear": -0.6069364, "regularMarketChangePercent": -1.8691682, "regularMarketPrice": 1.05, "shortName": "Repare Therapeutics Inc.", "longName": "Repare Therapeutics Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743203416, "regularMarketTime": 1743192000, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.1364001, "fiftyDayAverageChangePercent": -0.11496974, "twoHundredDayAverageChange": -1.548075, "twoHundredDayAverageChangePercent": -0.59585464, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]